Ukraine Introduces Updated Guidelines for Responsible Use of Antimicrobial Medications

Updated Protocols for Antimicrobial Use in Ukraine

According to Рубрика — Суспільство: Ukraine has officially adopted two new guidelines aimed at the rational use of antimicrobial drugs within both primary and specialized healthcare settings. These protocols establish standardized procedures for prescribing, reviewing, and discontinuing antimicrobial treatments. They form a key part of the nation’s comprehensive plan to combat antimicrobial resistance by 2030, ensuring these medications remain effective and are used appropriately.

Minister of Health Viktor Liashko announced that the new standards require all antimicrobial prescriptions to be well-documented in medical records or the electronic health system. Antibiotics should only be prescribed when there is confirmed or strongly suspected bacterial infection. Importantly, antimicrobials must not be given at the patient’s request without medical justification. In certain cases, bacteriological testing must be conducted before starting therapy. Treatment is reviewed after 48 to 72 hours to adjust or stop medication if necessary.

Antimicrobial Resistance: Classification and Challenges

When selecting antibiotics, healthcare providers use the WHO AWaRe classification, which categorizes drugs into three groups: Access, Watch, and Reserve. Reserve antibiotics are reserved strictly for specific situations.

The issue of antimicrobial resistance is particularly urgent in Ukraine due to the ongoing war, which results in numerous severe injuries, prolonged treatments, repeated medical interventions, and hospital-acquired infections. Globally, one in six bacterial infections no longer responds to antibiotic treatments. According to WHO estimates, by 2050, drug-resistant infections could cause over 10 million deaths annually worldwide. The economic impact is also staggering, with potential global losses exceeding $2 trillion. The declining effectiveness of antibiotics poses serious risks for complex surgeries, organ transplants, cancer treatments, and other critical medical procedures.

Ukraine is actively implementing its State Strategy to Combat Antimicrobial Resistance through 2030. This includes expanding microbiology laboratory networks, enhancing epidemiological surveillance, and improving infection control in healthcare facilities. The guideline for primary care offers recommendations on treating common bacterial infections in adults and children, including options for delayed prescriptions. For specialized care, treatment decisions are guided by laboratory results and local antibiotic sensitivity data, with clinical pharmacists overseeing prescriptions and requiring prior approval for reserve antibiotics. Additionally, there is a protocol to switch patients from intravenous to oral antibiotics based on their condition.

The adoption of these new standards highlights the increasing commitment of the Ukrainian government to address antimicrobial resistance, a critical public health threat. Given the heightened risk of bacterial infections amid ongoing conflict, these measures are expected to significantly enhance medical care quality and reduce patient risks.

Successful implementation will depend on thorough training of healthcare professionals and the integration of these guidelines into existing clinical protocols.